NaturalAntibody
PrivateLast Round
Grant
Dec 16, 2021
Total Funding Raised
$3.31M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
NaturalAntibody is a bioinformatics company that develops an AI-powered computational platform to accelerate the discovery and design of therapeutic antibodies.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Vertical SaaS
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NaturalAntibody Comparables
Compare NaturalAntibody with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ENPICOM | 82% | |
| Cyrus Biotechnology | 78% | |
| Siemens | 77% |
NaturalAntibody Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2021 | ||||
| Seed | Aug 24, 2021 |
NaturalAntibody Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| WP2 Investments | Seed |
| European Funds for a Modern Economy | Grant |
| Tar Heel Capital Pathfinder | Seed |
| National Centre for Research and Development | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Monthly visitors grew 82% MoM, reaching 5.9K.
- Mar 1, 2026
Monthly visitors increased 54% MoM.
NaturalAntibody Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about NaturalAntibody's valuation, stock price, and market status.
Is NaturalAntibody a public or private company?
NaturalAntibody is a private company.
What is the current stock price of NaturalAntibody?
NaturalAntibody is a private company with no public stock price. No recent secondary market data is available.
How much is NaturalAntibody worth (valuation)?
Valuation information for NaturalAntibody is not publicly available.
Can I buy NaturalAntibody stock?
NaturalAntibody shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was NaturalAntibody's last funding round?
NaturalAntibody's most recent funding round was Grant on December 16, 2021.
Who are the main investors in NaturalAntibody?
Key investors in NaturalAntibody include Tar Heel Capital Pathfinder.
Will NaturalAntibody IPO soon?
No public IPO plans have been announced for NaturalAntibody.
How can I track NaturalAntibody secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor NaturalAntibody's secondary market activity and sign up for updates.